You have 9 free searches left this month | for more free features.

Condition

Alzheimer Disease (1)

Alzheimer's (1)

Healthy Volunteers (1)

Lewy Body Dementia (1)

Non-DLB Dementia (1)

Parkinson Disease (1)

Parkinson's Syndrome (1)

Progressive Supranuclear Palsy (1)

Vascular Dementia (1)

Overall Status

Completed (2)

Unknown status (1)

Withdrawn (1)

Sign in for free

Phase

phase 3 (2)

early phase 1 (1)

phase 2 (1)

Sponsor

GE Healthcare (1)

Ken Marek, MD (1)

Molecular NeuroImaging (1)

Navidea Biopharmaceuticals (1)

Collaborator

Institute for Neurodegenerative Disorders (1)

Intervention

datscan (4)

[18f]florbetapir (1)

[18f]mni-958 (1)

nav5001 (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (4)

datscan

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Parkinson Disease Trial in Worldwide (DaTscan)

Unknown status

Parkinson Disease

DaTscan

Birmingham, Alabama
+33 more

Jul 15, 2020

Alzheimer, Healthy Volunteers, Progressive Supranuclear Palsy Trial in New Haven ([18F]MNI-958, [18F]Florbetapir, DaTscan)

Completed

Alzheimer Disease
+2 more

[18F]MNI-958
+2 more

New Haven, Connecticut

Molecular NeuroImaging, LLC

Mar 21, 2019

Parkinson's Syndrome Trial in Phoenix, Orlando (NAV5001, DaTscan)

Withdrawn

Parkinson's Syndrome

NAV5001
DaTscan

Phoenix, Arizona
+1 more

Sep 12, 2017

Lewy Body Dementia, Non-DLB Dementia, Alzheimer's Trial in Ismaning (DatSCAN)

Completed

Lewy Body Dementia
+3 more

DatSCAN

Ismaning, Germany

Amersham Buchler GmbH Co. KG

May 15, 2007